Efficacy News and Research

RSS
Understanding how angiogenesis contributes to drug resistance in breast cancer

Understanding how angiogenesis contributes to drug resistance in breast cancer

New class of antivirals shows promise against multiple viruses

New class of antivirals shows promise against multiple viruses

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer

Olaparib provides survival benefits for high-risk BRCA-positive breast cancer patients

Olaparib provides survival benefits for high-risk BRCA-positive breast cancer patients

TCR sequencing sheds light on tumor immune interactions in hepatocellular carcinoma

TCR sequencing sheds light on tumor immune interactions in hepatocellular carcinoma

Prostate cancer vaccines: Progress, challenges, and future directions

Prostate cancer vaccines: Progress, challenges, and future directions

Elevated PGE2 levels drive age-related skin changes and cancer risk

Elevated PGE2 levels drive age-related skin changes and cancer risk

Interim analysis of STOMP study finds no efficacy for tecovirimat in mild to moderate Mpox cases

Interim analysis of STOMP study finds no efficacy for tecovirimat in mild to moderate Mpox cases

Promising gene therapy could transform heart failure treatment

Promising gene therapy could transform heart failure treatment

New triplet therapies show promise for relapsed and newly diagnosed leukemias

New triplet therapies show promise for relapsed and newly diagnosed leukemias

Scientists uncover genetic code driving tumor formation and spread

Scientists uncover genetic code driving tumor formation and spread

New advances offer hope for patients with systemic mastocytosis

New advances offer hope for patients with systemic mastocytosis

Study provides the first evidence of genetic predisposition to breast cancer metastasis

Study provides the first evidence of genetic predisposition to breast cancer metastasis

Novel drug combination shows promise for CLL treatment

Novel drug combination shows promise for CLL treatment

New immunotherapeutic platform improves mRNA therapy efficacy against cancer

New immunotherapeutic platform improves mRNA therapy efficacy against cancer

Antibody trials show encouraging results in patients with high-risk forms of two blood cancers

Antibody trials show encouraging results in patients with high-risk forms of two blood cancers

Unprocessed red meat and weight loss: Is it a healthy choice?

Unprocessed red meat and weight loss: Is it a healthy choice?

New brain stimulation trial aims to improve cognitive recovery from TBI

New brain stimulation trial aims to improve cognitive recovery from TBI

Filgotinib offers new promise for managing Crohn’s disease

Filgotinib offers new promise for managing Crohn’s disease

$1.5 million grant supports alternatives to opioids initiative at University Hospitals

$1.5 million grant supports alternatives to opioids initiative at University Hospitals

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.